DW

Dede Willis

Founder of Orbit Genomics

Boulder, Colorado

Overview 

Dede Willis is a Life Sciences Entrepreneur based in Boulder, Colorado, with a strong background in cross-functional team leadership and technology transfer. Notable career highlights include serving as CEO and Co-Founder of Orbit Genomics and holding leadership roles in companies such as Boulder Diagnostics Inc. and Proligo LLC. Currently, Dede Willis is leveraging expertise in business strategy and commercialization to drive success in the life sciences sector, investing in companies at various stages and sectors, with a focus on BioTech in Colorado and Utah.

Work Experience 

  • CEO and CoFounder

    2016 - Current

    Orbit Genomics is transforming complex disease diagnosis, treatment and prevention through early warning genomics. Our patent pending OrbiSeq™ platform analyzes novel genomic markers which uniquely reflect not only inherited predisposition to disease, but also risk acquired from lifestyle and environmental exposures. OrbiSeq can be applied to diagnose, treat and help prevent complex diseases including cancer, heart disease and neurological diseases.

Orbit Genomics develops genome sequencing technology system for early disease detection, treatment, and prevention of complex diseases.

  • Partner

    2003

    Ventac Partners is a life science company builder with offices in the US, EU and Asia. Ventac Partners has a strong track record of successfully launching new companies, fundraising, deal making and strategic consulting.

Ventac Partners work to advance healthcare and biotechnology innovations and create the maximum value for inventors and investors.

  • Business Mentor

    2016 - 2020

  • Member Board of Directors

    2016 - 2019

    Panion Animal Health AB ‘s aim is develop and commercialize the canine application of CombiGene AB’s technology for gene therapeutic treatment of drug refractory epilepsy. In addition, Panion plans to inlicense or acquire other, similar assets, i.e. the animal health applications of human health development projects or products. Panion was acquired by CombiGene in 2019.

  • Chief Operating Officer and CoFounder

    2009 - 2014

    Boulder Diagnostics Inc. is dedicated to bringing new diagnostic tests to market for diseases that are not reliably diagnosed today. We work with leading academic institutions and innovative companies to identify scientific breakthroughs that can deliver new, reliable diagnostic tests where today’s standard methods fail.

  • Vice President, Operations

    2010 - 2012

  • Vice President Operations

    2004 - 2007

  • Vice President

    1999 - 2002

  • Managing Director

    1999 - 2002

  • President & CEO

    1998 - 1999

Articles About Dede

Relevant Websites